Bendamustine Hydrochloride for Injection
-
English name
Bendamustine Hydrochloride for Injection
-
approval number
National Medical Products Administration Approval H20249779 Injection Bendamustine Hydrochloride 25mg, National Medical Products Administration Approval H20249778 Injection Bendamustine Hydrochloride 100mg
-
norm
Calculated as C16H21Cl2N3O2 · HCl (1) 25 mg (2) 100 mg
-
Packaging specification
1 piece/bag x 1 bag/box
-
indications
Suitable for inert B-cell therapy during or after treatment with rituximab or rituximab containing regimens for disease progression Non Hodgkin's lymphoma (NHL).
